Develops small-molecule medicines for rare diseases and hematology.
| Title |
|---|
| Senior Director, Global Scientific Communications & Publications Full Time · $230K-$344K · 10+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Senior Director, Global Scientific Communications & Publications Full Time · $230K-$344K · 10+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Medical Director, Global Medical Affairs Full Time · 8+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Hemolytic Anemia Sales Specialist (St. Louis) Full Time · $157K-$236K · 5+ YOE Cambridge, Massachusetts, United States · Remote |
| Hemolytic Anemia Sales Specialist (St. Louis) Full Time · $157K-$236K · 5+ YOE Missouri or Illinois or Indiana · Remote |
| Director/Sr. Medical Director, Global Medical Affairs Full Time · $184K-$344K · 8+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Senior Director, Commercial Analytics Full Time · $230K-$344K · 12+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Senior Director, Commercial Analytics Full Time · 12+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Sr. Manager, G&A Business Systems Analyst, IT Full Time · $131K-$197K · 8+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Sr. Manager, G&A Business Systems Analyst, IT Full Time · $131K-$197K · 8+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Hemolytic Anemia Sales Specialist, Rare Genetic Diseases (New Jersey) Full Time · $157K-$236K · 5+ YOE Cambridge, Massachusetts, United States · Remote |
| Hemolytic Anemia Sales Specialist, Rare Genetic Diseases (New Jersey) Full Time · $157K-$236K · 5+ YOE Cambridge, Massachusetts, United States · Remote |
| Senior Manager, Medical Coding Full Time · $131K-$197K · 5+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Senior Manager, Medical Coding Full Time · $131K-$197K · 5+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Activities | Drug discoveryPharmaceutical researchClinical trial managementBiotechnology commercializationRare disease therapy development |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Agios Pharmaceuticals |
| Employees | 540 |
| Type | Public |
| Tagline | Develops small-molecule medicines for rare diseases and hematology. |
| Founded | 2,007 |
| Website | agios.com |
| Stock Exchange | NASDAQ |
| Stock Symbol | AGIO |